1,735 results on '"Giamarellos-Bourboulis, Evangelos J."'
Search Results
2. Towards personalized medicine: a scoping review of immunotherapy in sepsis
3. Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial
4. qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial
5. The pathophysiology of sepsis and precision-medicine-based immunotherapy
6. Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein
7. Adjunctive treatment in COVID-19 and sepsis—What did we learn?
8. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study*
9. Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control
10. Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
11. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine
12. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial
13. Fatty acid desaturation and lipoxygenase pathways support trained immunity
14. Immune responses of patients on maintenance hemodialysis after infection by SARS-CoV-2: a prospective observational cohort study
15. Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19
16. Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity
17. An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial
18. HEPARIN-BINDING PROTEIN LEVELS PREDICT UNFAVORABLE OUTCOME IN COVID-19 PNEUMONIA: A POST HOC ANALYSIS OF THE SAVE TRIAL
19. Performance evaluation of a PCR panel (FilmArray® Pneumonia Plus) for detection of respiratory bacterial pathogens in respiratory specimens: A systematic review and meta-analysis
20. Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes
21. A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis
22. Correction: Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control
23. A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019
24. Dimethyl itaconate induces long-term innate immune responses and confers protection against infection
25. REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI
26. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
27. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
28. Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled Phase 4 trial
29. Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial
30. Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial etiology
31. A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in Greece
32. eLife assessment: Anti-inflammatory therapy with nebulised dornase alfa for severe COVID-19 pneumonia
33. From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations For Developing Precision Medicine in ICU
34. An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
35. Redefining critical illness
36. Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
37. Clinical evidence supporting ceftaroline fosamil and ceftobiprole for complicated skin and soft tissue infections
38. Systematized and efficient: organization of critical care in the future
39. An animal model of limitation of gut colonization by carbapenemase-producing Klebsiella pneumoniae using rifaximin
40. Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial
41. High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure
42. A 6-mRNA host response classifier in whole blood predicts outcomes in COVID-19 and other acute viral infections
43. Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure
44. Author Correction: Transmission of trained immunity and heterologous resistance to infections across generations
45. From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU.
46. Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial
47. Transmission of trained immunity and heterologous resistance to infections across generations
48. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
49. Bimekizumab Response Maintenance to 48 Weeks in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled Responder Analysis from the Phase 3, Double-Blind, Placebo-Controlled, Randomized Clinical Trials BE HEARD I and II
50. Community-acquired pneumonia: the best candidates for clarithromycin – Authors' reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.